Knowledge of the roles that NaV1.1, NaV1.2, and NaV1.6 channels play in epilepsy has increased greatly in the past decade, yet the ability to predict the clinical outcome of a variant in any of these channels remains an unmet and important challenge. The gene discussed is SCN2A; the disease is epilepsy.